GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
B

Bio View BIOV.TA · ILA

Health Care · Tel Aviv · 🇮🇱 Israel

Compare

4,192.00

-3.45%

Close of 9 Nov 2026, in ILA

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in ILS, from our data supplier.

FY2025

Revenue

ILS 19.9m

FY2016FY2025

Net income

−ILS 15.3m

FY2016FY2025

Free cash flow

−ILS 3.1m

FY2016FY2025

Shareholders' equity

ILS 9.4m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueILS 19.9mILS 25.7mILS 34.8mILS 29.1mILS 30.5mILS 26.0mILS 35.8mILS 25.3mILS 27.8mILS 33.3m
Gross profitILS 8.7mILS 15.6mILS 21.4mILS 16.7mILS 17.6mILS 15.8mILS 20.3mILS 14.8mILS 16.6mILS 21.2m
Research and developmentILS 4.1mILS 6.7mILS 8.4mILS 4.9mILS 5.3mILS 5.4mILS 5.7mILS 265,000ILS 231,000ILS 5.7m
Operating income−ILS 7.9m−ILS 2.9mILS 766,000ILS 1.4mILS 3.0mILS 1.2mILS 3.4m−ILS 1.8m−ILS 1.4mILS 4.7m
Net income−ILS 15.3m−ILS 3.1mILS 383,000ILS 587,000ILS 2.2mILS 884,000ILS 2.5m−ILS 1.9m−ILS 1.3mILS 4.4m
Diluted earnings per share-1.10-0.240.030.040.170.060.18-0.14-0.090.34

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsILS 19.9mILS 33.6mILS 42.0mILS 41.9mILS 40.0mILS 33.9mILS 37.0mILS 33.4mILS 34.7mILS 38.7m
Cash and short-term investmentsILS 7.2mILS 10.9mILS 17.1mILS 19.4mILS 19.2mILS 17.2mILS 18.7mILS 18.0mILS 17.9mILS 22.2m
Total liabilitiesILS 10.5mILS 10.7mILS 14.7mILS 13.7mILS 12.9mILS 8.8mILS 12.0mILS 10.7mILS 11.3mILS 11.1m
DebtILS 2.8mILS 2.0mILS 3.5mILS 4.1mILS 4.6mILS 1.5mILS 2.5m———
Shareholders' equityILS 9.4mILS 22.9mILS 27.3mILS 28.3mILS 27.2mILS 25.1mILS 24.9mILS 22.7mILS 23.5mILS 27.6m
Shares outstanding14m13m14m14m13m14m14m14m14m13m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−ILS 3.1m−ILS 3.1mILS 153,000ILS 968,000ILS 3.2mILS 802,000ILS 2.5m−ILS 1.3mILS 54,000ILS 3.7m
Capital spending−ILS 53,000−ILS 35,000−ILS 274,000−ILS 457,000−ILS 659,000−ILS 304,000−ILS 208,000−ILS 180,000−ILS 202,000−ILS 119,000
Free cash flow−ILS 3.1m−ILS 3.1m−ILS 121,000ILS 511,000ILS 2.6mILS 498,000ILS 2.3m−ILS 1.5m−ILS 148,000ILS 3.6m
Dividends paid————————−ILS 2.8m−ILS 2.8m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueILS 5.0mILS 5.0mILS 5.3mILS 5.3mILS 4.6mILS 4.6mILS 4.3mILS 4.3m
Gross profitILS 2.4mILS 2.4mILS 2.7mILS 2.7mILS 2.1mILS 2.1mILS 2.0mILS 2.0m
Operating income−ILS 999,000−ILS 999,000−ILS 1.4m−ILS 1.4m−ILS 2.5m−ILS 2.5m−ILS 2.2m−ILS 2.2m
Net income−ILS 1.2m−ILS 1.2m−ILS 5.4m−ILS 5.4m−ILS 2.3m−ILS 2.3m−ILS 2.6m−ILS 2.6m
Diluted earnings per share-0.09-0.09-0.39-0.39-0.16-0.16-0.19-0.19
Cash from operations————−ILS 1.0m−ILS 1.0m−ILS 1.0m−ILS 1.0m
Total assetsILS 18.5mILS 18.5mILS 19.9mILS 19.9mILS 28.2mILS 28.2mILS 33.6mILS 33.6m
Cash and short-term investmentsILS 8.2mILS 8.2mILS 7.2mILS 7.2mILS 7.8mILS 7.8mILS 10.9mILS 10.9m
DebtILS 1.2mILS 1.2mILS 1.3mILS 1.3mILS 1.1mILS 1.1mILS 3.2mILS 1.6m
Shareholders' equityILS 6.7mILS 6.7mILS 9.4mILS 9.4mILS 19.9mILS 19.9mILS 22.9mILS 22.9m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-11.9%-5.1%-5.3%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin53.3%56.9%57.7%58.9%
Operating margin-23.7%-7.9%-2.7%1.3%
Net margin-40.5%-16.0%-8.7%-2.0%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings-151.3-1173.5—————-1634.8-4270.6—
Price to sales116.4144.0127.0182.4135.5217.2120.5119.9192.6145.3

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years. Last went ex-dividend on 22 Mar 2017.

FY2017
Paid in the year0.02
  • 10-for-1 split · 12 Dec 2023

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.